Uterine transplantation (UTx) is the only reproductive technology that provides a reproductive solution for women with absolute uterine factor infertility that allows them to gestate. Since the announcement of the first live birth following UTx, there has been considerable interest from the trans community regarding the possibility of uterine transplantation for transgender women. UTx offers the potential to realign reproductive capacity and widens the reproductive options for transgender women (Alghrani Journal of Law and the Biosciences 2018;5:301-28). Whilst not yet medically feasible, it is important to consider the medical barriers alongside the ethical, legal, and social issues that UTx in transgender women raises. Currently, this is an under-discussed area, and as such, Jones et al provide an important contribution to the literature (Jones et al. BJOG 2019; 126:152-6) . Jones et al. note that UTx in transgender women may be ethically and legally permissible owing to considerations of justice, equality, and non-discrimination. However, the importance of the paper is with regard to the education, elucidation, and discussion of the medical difficulties requiring further investigation prior to any attempts.
What is apparent is that the medical barriers are not insurmountable. A utero-vaginal transplant is suggested owing to the need to utilise as much donor vagina as possible, with it further recommended that retrieval be from deceased donors because of the more radical hysterectomy. Controversially, female-to-male transgender men are also suggested as possible donors. There is a need to balance the interests of living donors and recipients: living donors should not be exposed to unnecessary risks in order to increase benefits to recipients. This suggestion requires further legal, ethical, and medical evaluation. The trans-community needs information about the possibility of UTx, and Jones et al. demonstrate the need for further research before any attempts at UTx in transgender women.
Whilst ethical and legal considerations have been alluded to, contemplation of these issues is vital before further medical advances, particularly as UTx in transgender women also raises the possibility of male pregnancy. It is undeniable that transgender people must not be discriminated against; however, currently in the United Kingdom, it appears that embryo transfer into a person who was not born a woman is illegal [s3(2) (a) and s3ZA (6)(a) HFE Act 1990 (as amended)]. Therefore, even if it were medically feasible to perform UTx on transgender women, they would not be able to undergo embryo transfer and subsequent pregnancy.
Ethical debate and deliberation must also be given to justice, equality, and procreative liberty (amongst others). Robertson (Journal of Law and the Biosciences 2017;4:630-6) and Alghrani (Journal of Law and the Biosciences 2016;3:636-41 and Journal of Law and the Biosciences 2018;5:601-28) have started the debate on the right to gestate in light of UTx, and the establishment of this right will be vital to support transgender women accessing UTx.
The medical problems discussed by Jones et al. must be debated alongside the ethics and legality of providing UTx to transgender women. To ensure that any future legislation is fit for purpose, it is imperative that there is proactive debate of the ethics of UTx to avoid reactive legislation that may be implemented once UTx is proven to be a medically safe and effective treatment. Only through proactive debate encompassing all aspects can reasoned decisions on UTx for transgender women be made. 
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